(glutamyl-glutamyl-asparaginyl-valyl)6

03/01/1992 - "falciparum ring erythrocyte surface antigen (Pf155/RESA) (EENV)6 were examined in 423 individuals (age range 30 days-78 years) living in a malaria holoendemic area of Liberia. "
07/01/1991 - "A significant association was observed between presence of antibodies to the 3' repeat region peptide (EENV)6 and resistance to clinical malaria. "
10/01/1994 - "The levels of Ag332 (2-12)2-reactive antibodies in individual sera as well as in the study population as a whole correlated well with the levels of antibodies to the Pf155/RESA peptide (EENV)6. However, there was no correlation between anti-(EENV)6 and anti-Ag332 (2-12)2 antibody levels and malaria parasitemia. "
08/01/1996 - "However, infants with haemoglobin AS whose cord blood was seropositive for antibodies to the (EENV)6 or (NANP)6 peptide showed delayed onset (P < 0.001) of malaria compared with AA seropositive infants. "
09/01/1992 - "This haplotype was significantly associated with higher than average levels of antibody to a peptide epitope, (EENV)6, of the malaria antigen Pf155/RESA. "

02/01/1991 - "No statistically significant correlation was found between seropositivity to (EENV)6 and malarial parasitemia. "
10/01/1994 - "The levels of Ag332 (2-12)2-reactive antibodies in individual sera as well as in the study population as a whole correlated well with the levels of antibodies to the Pf155/RESA peptide (EENV)6. However, there was no correlation between anti-(EENV)6 and anti-Ag332 (2-12)2 antibody levels and malaria parasitemia. "